COURSE AND MANAGEMENT OF MYASTHENIA GRAVIS
- 10 October 1953
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 153 (6), 529-532
- https://doi.org/10.1001/jama.1953.02940230001001
Abstract
Since myasthenia gravis is a disease that is subject to spontaneous remissions and exacerbations, it is difficult to evaluate the effect of procedures that are intended to alter the course of this disease. There has been considerable difference of opinion concerning the effect of thymectomy1 and of irradiation of the thymus.2 Preliminary observations on the effect of thymectomy suggested that the rate and degree of remission following this operation were greater than would be expected to occur spontaneously.3 Because 12 years have elapsed since these observations were begun, a review of this problem, in which the course of patients who have had thymectomy or irradiation of the thymus are compared with patients of comparable severity of illness who have had neither procedure, seems appropriate. A total of 202 patients with generalized myasthenia gravis have been studied in the Johns Hopkins Hospital from 1 to 34 years, theKeywords
This publication has 4 references indexed in Scilit:
- EFFECT OF ADRENOCORTICOTROPIC HORMONE (ACTH) AND CORTISONE ADMINISTRATION IN PATIENTS WITH MYASTHENIA GRAVIS AND REPORT OF ONSET OF MYASTHENIA GRAVIS DURING PROLONGED CORTISONE ADMINISTRATION1952
- TREATMENT OF MYASTHENIA GRAVIS WITH OCTAMETHYL PYROPHOSPHORAMIDEJAMA, 1951
- OBSERVATIONS ON THE EFFECTS OF TETRAETHYL PYROPHOSPHATE (TEPP) IN MAN, AND ON ITS USE IN THE TREATMENT OF MYASTHENIA GRAVIS1949
- THE TREATMENT OF MYASTHENIA GRAVIS BY REMOVAL OF THE THYMUS GLANDJAMA, 1941